MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation Total Non Current Liabilities 2011-2026 | DHR
Annual Total Non Current Liabilities Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 26.9 B | 14.8 B | 15.5 B | 15.3 B | 18.3 B | 8.15 B | 7.69 B | 9.65 B | 8.81 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.9 B | 7.69 B | 13.9 B |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
3.29 B | $ 114.84 | -0.55 % | $ 34.9 B |  USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.3 | 0.62 % | $ 175 M |  China |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
62.1 M | $ 15.36 | 1.92 % | $ 1.99 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 27.2 | 0.33 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 17.82 | -2.68 % | $ 950 M | USA |
 |
Anixa Biosciences
ANIX
|
4.17 M | $ 2.59 | 1.57 % | $ 84.1 K | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.15 | -4.17 % | $ 6.26 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
574 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 168.22 | -3.26 % | $ 8.34 B | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 24.73 | -0.44 % | $ 687 M | USA |
 |
Celcuity
CELC
|
69.2 K | $ 114.22 | 1.41 % | $ 5.34 B | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
1.15 B | $ 63.21 | 1.59 % | $ 24.7 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 198.96 | 0.91 % | $ 22.1 B | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Guardant Health
GH
|
91.4 M | $ 89.66 | -4.44 % | $ 11.2 B | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 109.62 | -4.0 % | $ 9.04 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.97 | 0.63 % | $ 8.72 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 127.74 | 0.28 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
13 B | $ 170.72 | -1.47 % | $ 29.3 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 274.46 | 0.27 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 75.89 | -0.28 % | $ 5.12 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 496.0 | -0.47 % | $ 14.3 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 266.63 | 0.53 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.67 | -1.68 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
843 K | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
435 M | $ 8.02 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 9.56 | 1.59 % | $ 2.07 B | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 17.33 | 0.99 % | $ 388 M | USA |